Health Care :: $153 million for Home and Community Care in WA
Thousands of older people and people with a disability in Western Australia are set to benefit from a $12 million boost in funding for Home and Community Care services in the state.
Thousands of older people and people with a disability in Western Australia are set to benefit from a $12 million boost in funding for Home and Community Care services in the state.
The Australian Government will provide more than $70 million in additional funding to Medicare for diagnostic imaging and pathology services.
Laboratory results with the NPRL2 tumor suppressor gene demonstrated that infusions of NPRL2 nanoparticles in combination with cisplatin resulted in a 90 percent inhibition of tumor growth in human lung cancer cells compared to control treatments, reported Introgen Therapeutics, Inc. (Nasdaq: INGN – News).
Stretching out a dose of chemotherapy over six or more hours may reduce the risk of heart problems caused by certain commonly used chemotherapy drugs, according to a new review of recent research.
Bacteria that can cause deadly infections in humans and animals have shown promise in treating cancer by ?eating? tumors from the inside out. Now, two new studies at the Johns Hopkins Kimmel Cancer Center have demonstrated that, combined with specially-packaged anti-cancer drugs, the bacterial therapy?s prospects for cancer eradication have dramatically improved.
The scientific evidence is strong enough to justify using folic acid as a cheap and simple way of reducing heart disease and strokes, say researchers in this week?s BMJ.
A new study shows that blood flow to the legs is relatively normal in people with diastolic heart failure, suggesting other potential causes of their inability to do everyday activities, according to researchers at Wake Forest University Baptist Medical Center.
The British Heart Foundation (BHF) today launches its Doubt Kills campaign, urging people to call 999 immediately if they experience chest pain. The campaign aims to help reduce death and disability from coronary heart disease, which remains the UK?s single biggest killer.
King Pharmaceuticals, Inc. (NYSE: KG) and Depomed, Inc. (NASDAQ: DEPO) today announced the launch of a new program that will provide support for patients with diabetes who are receiving treatment with Glumetza (metformin hydrochloride extended-release tablets), a new once-daily extended-release metformin formulation that features AcuForm drug-delivery technology.
People taking a widely used medication to strengthen fragile, aging bones may also be protecting their joints, according to a recent study led by Johns Hopkins rheumatologist Clifton Bingham, M.D.